がん紙が引き下げられた.

D McNamee

Lancet (London, England)

|May 10, 2001

まとめ

No abstract available in PubMed .

関連する概念動画

こちらも読む

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

New drug classes 2001.

Lancet (London, England)·2001

Same author

Tackling venomous snake bites worldwide.

Lancet (London, England)·2001

Same author

Review of clinical protocols at The Lancet.

Lancet (London, England)·2001

Same author

Pies flying low in a blue sky.

Lancet (London, England)·2000

Same author

Ovarian-cancer results cause a stir at cancer conference.

Lancet (London, England)·2000

Same author

Pharmacovigilance into 2000.

Lancet (London, England)·1999

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

関連する実験動画

がん紙が引き下げられた.

関連する概念動画

New drug classes 2001.

Tackling venomous snake bites worldwide.

Review of clinical protocols at The Lancet.

Pies flying low in a blue sky.

Ovarian-cancer results cause a stir at cancer conference.

Pharmacovigilance into 2000.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

がん紙が引き下げられた.

関連する概念動画

New drug classes 2001.

Tackling venomous snake bites worldwide.

Review of clinical protocols at The Lancet.

Pies flying low in a blue sky.

Ovarian-cancer results cause a stir at cancer conference.

Pharmacovigilance into 2000.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

がん紙が引き下げられた.

関連する概念動画

関連記事

New drug classes 2001.

Tackling venomous snake bites worldwide.

Review of clinical protocols at The Lancet.

Pies flying low in a blue sky.

Ovarian-cancer results cause a stir at cancer conference.

Pharmacovigilance into 2000.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

関連する実験動画

がん紙が引き下げられた.

関連する概念動画

関連記事

New drug classes 2001.

Tackling venomous snake bites worldwide.

Review of clinical protocols at The Lancet.

Pies flying low in a blue sky.

Ovarian-cancer results cause a stir at cancer conference.

Pharmacovigilance into 2000.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.